Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention

References

• AlwaII N, Johnsson S, Tornberg A, Werk6 L. Acute renal failure following angiography. Acta Chir Scand 1955; 109:11–19.
   Google Scholar
• Barrett BJ, Carlisle EJ. Meta-analysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media. Radiology 1993; 188:171–178.
   PubMed Web of Science ®Google Scholar
• Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and non-ionic contrast media in 1196 patients:a randomized trial. The lohexol Cooperative Study. Kidney Int 1995; 47:254–261.
   PubMed Web of Science ®Google Scholar
• Thomsen HS. Nephrotoxicity. Thomsen HS, Muller RN, Mattrey RF editors. Trends in contrast media. Springer Berlin, Heidelberg, New York 1999:103–116.
   Google Scholar
• Katzberg RW, Haller C. Contrast-induced nephrotoxicity:clinical landscape. Kidney Int 2006; 69:53–57.
   Web of Science ®Google Scholar
• Morcos SK. Prevention of contrast media nephrotoxicity - the story so far. Clin Radiol 2004; 59:381–389.
   PubMed Web of Science ®Google Scholar
• Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, MacManamon PJ. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Eng J Med 1989; 320:143–149.
   PubMed Web of Science ®Google Scholar
• Morcos SK, Thomsen HS, Webb JAV. Contrast-media-induced nephrotoxicity:a consensus report. Eur Radiol 1999; 9:1602–1613.
   PubMed Web of Science ®Google Scholar
• Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol. 2004; 183:1673–1689.
   PubMed Web of Science ®Google Scholar
• Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89:615–620.
   PubMed Web of Science ®Google Scholar
• Davidson CJ, Hllatky M, Morris KG, Pieper K, Skelton TN, Schwab SJ, Bashore TM. Cardiovascular and renal toxicity of a non-ionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Int Med 1989; 110:119–124.
   PubMed Web of Science ®Google Scholar
• Nyman U, Almén T, Aspelin P, Hellstrom M, Kristiansson M, Sterner G. Contrast-medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min. Acta Radiol 2005; 46:830–842.
   PubMed Web of Science ®Google Scholar
• Becker CR, Reiser MF. Use of iso-osmolar non-ionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment. Invest Radiol 2005; 40:672–675.
   Web of Science ®Google Scholar
• Haglund M, Hesselstrand R, Nyman U, Sterner G. Contrast-induced nephropathy after computer tomography. Hydration and adapted contrast media dosage for the best prophylaxis. Lakartidningen 2005; 102:2864–2870.
   Google Scholar
• Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275:1489–1494.
   PubMed Web of Science ®Google Scholar
• McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention:incidence, risk factors, and relationship to mortality. Am J Med 1997; 103:368–375.
   PubMed Web of Science ®Google Scholar
• Dangas G, lakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005; 95:13–19.
   PubMed Web of Science ®Google Scholar
• Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105:2259–2264.
   PubMed Web of Science ®Google Scholar
• Reinecke H, Fobker M, Wellmann J, Becke B, Fleiter J, Heitmeyer C, Breithardt G, Hense HW, Schaefer RM. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy:The Dialysis-versus-Diuresis (DVD) Trial. Clin Res Cardiol 2007; 96 (3):130–139.
   Web of Science ®Google Scholar
• Asif A, Preston RA, Roth D. Radio-contrast-induced nephropathy. Am J Ther 2003; 10:137–147.
   PubMedGoogle Scholar
• Mehran R, Aymong ED, Nikolsky E, Lasic Z, lakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Loco MB, Dangas G. >A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 2004; 44:1393–1399.
   PubMed Web of Science ®Google Scholar
• Nikolsky E. Contrast-induced nephropathy:definition, epidemiology, and patients at risk. Kidney Int Suppl 2006; 69; (Suppl 100):S11–S15.].
   Google Scholar
• Freeman RV, O’Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, DeFranco AC, Eagle KA, McGinnity JG, Patel K, Maxwell-Eward A, Bondie D, Moscucci M. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90:1068–1073.
   PubMed Web of Science ®Google Scholar
• Ahuja TS, Niaz N, Agraharkar M. Contrast-induced nephrotoxicity in renal allograft recipients. Clin Nephrol 2000; 54:11–14.
   PubMed Web of Science ®Google Scholar
• McCarthy CS, Becker JA. Multiple myeloma and contrast media. Radiology 1992; 183:519–521.
   PubMed Web of Science ®Google Scholar
• Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O’Neill WW. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93:1515–1519.
   PubMed Web of Science ®Google Scholar
• Chen M-L, Lesko L, Williams RL. Measures of exposure versus measures of rate and extent of absorption. Clin Pharmacokinet 2001; 40:565–572.
   PubMed Web of Science ®Google Scholar
• Sherwin PF, Cambron R, Johnson JA, Pierro JA. Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radio-contrast-induced nephropathy. Invest Radiol 2005; 40:598–603.
   PubMed Web of Science ®Google Scholar
• Duncan L, Heathcote J, Djurdjev O, Levin A. Screening for renal disease using serum creatinine:who are we missing. Nephrol Dial Transplant 2001; 16:1042-1046.
   PubMed Web of Science ®Google Scholar
• Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function - measured and estimated glomerular filtration rate. N Eng J Med 2006; 354:2473–2483.
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, Stevens LA, Zhang Y, Hendriksen S, Kusek JW, Van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Int Med 2006; 145:247–254.
   PubMed Web of Science ®Google Scholar
• Björk J, Back S-E, Sterner G, Carlson J, Lindstrom V, Bakoush O,Simonsson P, Grubb A, Nyman U. Prediction of relative GFR in adults. New improved equations based on Swedish. Caucasians and standardized plasma-creatinine assays. Accepted for pub in Scand J Clin Lab Invest.
   Google Scholar
• Grubb A, Nyman U, Björk J, Lindstrom V, Rippe B, Sterner G, Christensson A. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equation for children. Clin Chem 2005; 51:1420–1431.
   PubMed Web of Science ®Google Scholar
• K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl 1):S1–5246.
   Google Scholar
• Contrast-induced nephropathy:Clinical insights and practical guidance. A report from the CIN consensus working panel. Am J Cardiol 2006; 98 (Suppl):1K–77K.
   Google Scholar
• Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 1996; 6:162–166.
   PubMed Web of Science ®Google Scholar
• Sam AD, Morasch MD, Collins J, Song G, Chen R, Pereles FS. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 2003; 38:313–318.
   PubMed Web of Science ®Google Scholar
• Ergün I, Keven K, Uruc I, Ekmekci Y, Canbakan B, Erden I, Karatan O. The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol Dial Transplant 2006; 21:697–700.
   PubMed Web of Science ®Google Scholar
• Briguori C, Colombo A, Airoldi F, Melzi G, Michev I, Carlino M, Montorfano M, Chieffo A, Bellanca R, Ricciardelli B. Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures. Catheter Cardiovasc Intery 2006; 67:175–180.
   Web of Science ®Google Scholar
• Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS. Nephrogenic systemic fibrosis:suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17:2359–62.
   PubMed Web of Science ®Google Scholar
• Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis. Nephrol Dial Transplant 2006; 21:1104–1108.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Information for Healthcare Professionals Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging Scans (marketed as Omniscan, OptiMARK, Magnevist, ProHance, and MultiHance). Accessed February 9, 2007 http://www.fda.gov/cder/drug/InfoSheets/HCP/gcca_200612HCP.htm.
   Google Scholar
• Mueller C. Prevention of contrast-induced nephropathy with volume supplementation. Kidney Int 2006; 69:S16–S19.
   Web of Science ®Google Scholar
• Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, Hewett J. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephropathy. Nephron Clin Pract 2003; 93:c29–c34.
   PubMed Web of Science ®Google Scholar
• Thomsen H. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR 2003; 181:1463–1471.
   PubMed Web of Science ®Google Scholar
• Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA, Rittase RA, Norton HJ. Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate:a randomized controlled trial. JAMA 2004; 291:2328–2334.
   PubMed Web of Science ®Google Scholar
• Briguori C, Airoldi F, DAndrea D, Bonizzone E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A. Renal insufficiency following contrast media administration trial (REMEDIAL):a randomized comparison of 3 preventive strategies. Circulation 2007; 115:1211-1217.
   Google Scholar
• Stacul F, Adam A, Becker CR; Davidson C, Lameire N, McCullough PA, Tumlin J. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006; 98 (suppl):59K–77K.
   Google Scholar
• Tepel M, Van der Giet M, Schwarzfeld C, Laufer U, Lierman D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Eng J Med 2000; 343:180–184.
   PubMed Web of Science ®Google Scholar
• Nallamothu BK, Shojania KG, Saint S, Hofer TP, Humes HD, Moscucci M, Bates ER. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analyses. Am J Med 2004; 117:938–947.
   PubMed Web of Science ®Google Scholar
• Biondi-Zoccai GGL, Lotrionte M, Abbate A, Testa L, Remigi E, Burzotta F, Valgimigli M, Romagnoli E, Crea F, Agostoni P. Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy:case study. BMJ 2006; 332:1–8.
   Google Scholar
• Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004; 15:407–410.
   PubMed Web of Science ®Google Scholar
• Erley C. Concomitant drugs with exposure to contrast media. Kidney Int 2006; 69:S20–S24.
   Web of Science ®Google Scholar
• Sterner G, Frennby B, Kurkus J, Nyman U. Does post-angiographic hemodialysis reduce the risk of contrast-medium nephropathy? Scand J Urol Nephrol 2000; 34:323–326.
   PubMed Web of Science ®Google Scholar
• Deray G. Dialysis and iodinated contrast media. Kidney Int 2006; 69:S25–S29.
   Web of Science ®Google Scholar
• Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Eng J Med 2003; 349:1333–1340.
   PubMed Web of Science ®Google Scholar
• Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348:491–499.
   PubMed Web of Science ®Google Scholar
• Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB, Kim HS. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography:the RECOVER study:a randomized controlled trial. J Am Coll Cardiol. 2006; 48:924–30.
   PubMed Web of Science ®Google Scholar
• McCullough PA, Bertrand ME, Brinker JA, Stacul F. A meta-analysis of the renal safety of iso-osmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 2006; 48:692–699.
   PubMed Web of Science ®Google Scholar
• Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005; 68:14–22.
   PubMed Web of Science ®Google Scholar
• Elmstahl B (2006) Are gadolinium contrast media really less nephrotoxic than iodine agents in radiographic examinations? A comparison in relation to their ability to attenuate x-rays in a pig model. In: Lund University Faculty of Medicine. Doctoral Dissertation Series 2006; 9, Lund, Sweden.
   Google Scholar
• Spinosa DJ, Kaufmann JA, Hartwell GD. Gadolinium chelates in angiography and interventional radiology:a useful alternative to iodinated contrast media for angiography. Radiology 2002; 223:319–325; discussion 326-317.
   PubMed Web of Science ®Google Scholar
• Remy-Jardin M, Bahepar J, Lafitte JJ, et al. Multi-detector row CT angiography of pulmonary circulation with gadolinium-based contrast agents:prospective evaluation in 60 patients. Radiology 2006; 238:1022-1035.
   PubMed Web of Science ®Google Scholar
• Briguori C, Colombo A, Airoldi F, Melzi G, Michev I, Carlino M, Montorfano M, Chieffo A, Bellanca R, Ricciardelli B. Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures. Cath Cardiovasc Interventions 2006; 67:175–180.
   Web of Science ®Google Scholar
• Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med. 1990; 150:1237–1242.
   PubMedGoogle Scholar
• Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44:1780–5.
   PubMed Web of Science ®Google Scholar
• Holmquist F, Nyman U. Eighty-peak kilovoltage 16-channel multidetector computed tomography and reduced contrast-medium doses tailored to body weight to diagnose pulmonary embolism in azotemic patients. Eur Radiol 2006; 16:1165–1176.
   PubMed Web of Science ®Google Scholar
• Sterner G, Nyman U, Valdes T. Low risk of contrast medium induced nephropathy with modern angiographic technique. J Int Med 2001; 250:429–434.
   PubMed Web of Science ®Google Scholar
• Farinas PL. A new technique for the arteriographic examination of the abdominal aorta and its branches. AJR 1941; 46:641–645.
   Google Scholar
• Awai K, Hon S. Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol. 2003; 13:2155–2160.
   PubMed Web of Science ®Google Scholar